Trial Profile
Measurement of patient reported gastrointestinal (GI) and health-related quality of life (HRQL) outcomes in liver transplant recipients (MyLiver).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Nov 2015
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary)
- Indications Liver transplant rejection
- Focus Therapeutic Use
- Acronyms MyLiver
- Sponsors Novartis
- 16 Jun 2009 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
- 16 Jun 2009 Planned number of patients changed from 194 to 34 as reported by ClinicalTrials.gov.
- 16 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.